In multiple sclerosis lesions, olig2 displays a differential expression pattern, which prevails in maturing oligodendrocytes at the active lesion borders, rather than chronic silent and shadow plaques (Wegener et al. 2015). Here, OLIG2 is linked to multiple sclerosis.